151 related articles for article (PubMed ID: 25973042)
1. Cullin-1 promotes cell proliferation via cell cycle regulation and is a novel in prostate cancer.
Jiang H; He D; Xu H; Liu J; Qu L; Tong S
Int J Clin Exp Pathol; 2015; 8(2):1575-83. PubMed ID: 25973042
[TBL] [Abstract][Full Text] [Related]
2. Cullin-1 promotes cell proliferation in human breast cancer and is related to diabetes.
Zhou YH; Xia J; Xu WH; Zhu X; Wu XH; Hua D; Xing C
Int J Biol Markers; 2016 Dec; 31(4):e375-e381. PubMed ID: 27312587
[TBL] [Abstract][Full Text] [Related]
3. PSCA promotes prostate cancer proliferation and cell-cycle progression by up-regulating c-Myc.
Li E; Liu L; Li F; Luo L; Zhao S; Wang J; Kang R; Luo J; Zhao Z
Prostate; 2017 Dec; 77(16):1563-1572. PubMed ID: 28971496
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical detection of tyrosine phosphatase SHP-1 predicts outcome after radical prostatectomy for localized prostate cancer.
Tassidis H; Brokken LJ; Jirström K; Ehrnström R; Pontén F; Ulmert D; Bjartell A; Härkönen P; Wingren AG
Int J Cancer; 2010 May; 126(10):2296-307. PubMed ID: 19795453
[TBL] [Abstract][Full Text] [Related]
5. Overexpressed Rce1 is positively correlated with tumor progression and predicts poor prognosis in prostate cancer.
Huang L; Li M; Wang D; He J; Wu W; Zeng Q; Li J; Xiao M; Hu J; He Y; Li Y; Mai L; Liu W
Hum Pathol; 2016 Jan; 47(1):109-14. PubMed ID: 26546252
[TBL] [Abstract][Full Text] [Related]
6. SHCBP1 promotes tumor cell proliferation, migration, and invasion, and is associated with poor prostate cancer prognosis.
Xu N; Wu YP; Yin HB; Chen SH; Li XD; Xue XY; Gou X
J Cancer Res Clin Oncol; 2020 Aug; 146(8):1953-1969. PubMed ID: 32447485
[TBL] [Abstract][Full Text] [Related]
7. Knockdown of CUL4B inhibits proliferation and promotes apoptosis of colorectal cancer cells through suppressing the Wnt/β-catenin signaling pathway.
Song B; Zhan H; Bian Q; Li J
Int J Clin Exp Pathol; 2015; 8(9):10394-402. PubMed ID: 26617747
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of Pleomorphic Adenoma Gene-Like 2 Is a Novel Poor Prognostic Marker of Prostate Cancer.
Guo J; Wang M; Wang Z; Liu X
PLoS One; 2016; 11(8):e0158667. PubMed ID: 27537362
[TBL] [Abstract][Full Text] [Related]
9. [Effect of downregulation of prostate cancer antigen-1 expression on malignant biological behavior of prostate cancer LNCaP cells].
Liu BQ; Wang YK; Wu YD; Wei JX; Li X
Zhonghua Zhong Liu Za Zhi; 2013 Nov; 35(11):828-32. PubMed ID: 24447480
[TBL] [Abstract][Full Text] [Related]
10. CMTM5 is reduced in prostate cancer and inhibits cancer cell growth in vitro and in vivo.
Xiao Y; Yuan Y; Zhang Y; Li J; Liu Z; Zhang X; Sheng Z; Xu T; Wang X
Clin Transl Oncol; 2015 Jun; 17(6):431-7. PubMed ID: 25387568
[TBL] [Abstract][Full Text] [Related]
11. Prostate specific G protein coupled receptor is associated with prostate cancer prognosis and affects cancer cell proliferation and invasion.
Cao W; Li F; Yao J; Yu J
BMC Cancer; 2015 Nov; 15():915. PubMed ID: 26582057
[TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of the TREK-1 K2P potassium channels in prostate cancer.
Zhang GM; Wan FN; Qin XJ; Cao DL; Zhang HL; Zhu Y; Dai B; Shi GH; Ye DW
Oncotarget; 2015 Jul; 6(21):18460-8. PubMed ID: 25962960
[TBL] [Abstract][Full Text] [Related]
13. KDM5C is overexpressed in prostate cancer and is a prognostic marker for prostate-specific antigen-relapse following radical prostatectomy.
Stein J; Majores M; Rohde M; Lim S; Schneider S; Krappe E; Ellinger J; Dietel M; Stephan C; Jung K; Perner S; Kristiansen G; Kirfel J
Am J Pathol; 2014 Sep; 184(9):2430-7. PubMed ID: 25016185
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of a novel candidate oncogene KIF14 correlates with tumor progression and poor prognosis in prostate cancer.
Zhang Y; Yuan Y; Liang P; Zhang Z; Guo X; Xia L; Zhao Y; Shu XS; Sun S; Ying Y; Cheng Y
Oncotarget; 2017 Jul; 8(28):45459-45469. PubMed ID: 28525372
[TBL] [Abstract][Full Text] [Related]
15. Cullin-1 regulates MG63 cell proliferation and metastasis and is a novel prognostic marker of osteosarcoma.
Cheng Q; Yin G
Int J Biol Markers; 2017 May; 32(2):e202-e209. PubMed ID: 28315506
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-194 acts as a prognostic marker and inhibits proliferation in hepatocellular carcinoma by targeting MAP4K4.
Zhao Y; Li F; Zhang X; Liu A; Qi J; Cui H; Zhao P
Int J Clin Exp Pathol; 2015; 8(10):12446-54. PubMed ID: 26722431
[TBL] [Abstract][Full Text] [Related]
17. Cellular interactions of the phosphorylated form of AKT in prostate cancer.
Hammerich KH; Frolov A; Li R; Ittmann M; Ayala GE
Hum Pathol; 2017 May; 63():98-109. PubMed ID: 28300578
[TBL] [Abstract][Full Text] [Related]
18. Coatomer subunit beta 2 (COPB2), identified by label-free quantitative proteomics, regulates cell proliferation and apoptosis in human prostate carcinoma cells.
Mi Y; Sun C; Wei B; Sun F; Guo Y; Hu Q; Ding W; Zhu L; Xia G
Biochem Biophys Res Commun; 2018 Jan; 495(1):473-480. PubMed ID: 29129687
[TBL] [Abstract][Full Text] [Related]
19. Prognostic value of ZFP36 and SOCS3 expressions in human prostate cancer.
Zhu JG; Yuan DB; Chen WH; Han ZD; Liang YX; Chen G; Fu X; Liang YK; Chen GX; Sun ZL; Liu ZZ; Chen JH; Jiang FN; Zhong WD
Clin Transl Oncol; 2016 Aug; 18(8):782-91. PubMed ID: 26563146
[TBL] [Abstract][Full Text] [Related]
20. Expression patterns of candidate susceptibility genes HNF1β and CtBP2 in prostate cancer: association with tumor progression.
Debiais-Delpech C; Godet J; Pedretti N; Bernard FX; Irani J; Cathelineau X; Cussenot O; Fromont G
Urol Oncol; 2014 May; 32(4):426-32. PubMed ID: 24332637
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]